GLP-1 Agonists: A Potential Breakthrough in Cancer Therapy Deborah Phippard, chief scientific officer at Precision for Medicine, believes that GLP-1…
Browsing: Oncology
The field of bispecific antibody drugs is gaining attention in the oncology market, with the potential to disrupt the dominance…
China’s Rise in the Global Oncology Market China has rapidly emerged as a global force in oncology, making significant contributions…
Antibody-drug conjugates (ADCs) were the highlight of this year’s annual meeting of the American Society of Clinical Oncology, sparking excitement…
One way Astellas is doing this is through collaborations with other companies to create what Zieler calls “modalities of the…
Ohio-based Kettering Health faced a significant challenge when a cyberattack led to a system-wide IT outage starting on May 20.…
The field of oncology has become increasingly complex in recent years, with a multitude of subtypes within what were once…
The pharmaceutical industry is gearing up for a busy 2025, with a focus on research and development to fill gaps…
